Core Viewpoint - The article highlights the successful completion of nearly 100 million RMB in Series B financing for Jinghai Weixiang Biotech Co., Ltd., which will enhance the company's technological advancements, production capacity, and market expansion in the biobased materials sector [1][3]. Group 1: Financing and Growth - The Series B financing was exclusively invested by Jiazhih Fund, with Kaicheng Capital serving as the advisor and continuing to assist in subsequent fundraising efforts [1]. - The funds will primarily be used for expanding the production capacity of the company's scale-up production base, iterative research and development of next-generation technologies, and market channel expansion [3]. - The company has achieved significant milestones in the industrialization of biobased materials, with steady increases in production capacity and market share, and this financing will further accelerate its growth process and solidify its industry-leading position [3]. Group 2: Technological Advancements - Jinghai Weixiang has developed several internationally leading production technologies for the entire biobased materials industry chain, focusing on key breakthroughs such as "non-grain biomass utilization," "next-generation industrial strains," "gypsum-free lactic acid technology," and "rPLA recycling" [2]. - The "gypsum-free lactic acid technology" addresses the environmental pollution caused by gypsum waste in traditional lactic acid production, enabling cleaner and lower-cost production [2]. - The "rPLA recycling" process not only allows for the recycling of polylactic acid (PLA) but also effectively reduces production costs, contributing to a sustainable development cycle for biobased materials [2]. Group 3: Product and Market Applications - The core product, polylactic acid (PLA), is a high-performance biodegradable material with excellent biocompatibility, degradability, and processing capabilities, widely used in various sectors including fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [2]. - With its comprehensive industry chain layout, Jinghai Weixiang can control the entire process from raw material supply to biobased material production and recycling, ensuring product quality stability and providing significant cost advantages and market competitiveness [2].

Core Viewpoint - The article discusses the recent financing of Shanghai Jinghai Weixiang Biological Materials Co., Ltd., which aims to leverage biomanufacturing technology to build a green and low-carbon supercell factory, focusing on PLA (polylactic acid) as its core product [2][3]. Financing and Growth - Jinghai Weixiang completed nearly 100 million yuan in B-round financing, led by Jiazhih Fund, which will support core technology development, capacity expansion, and market growth [2][4]. - The company is preparing for a B+ round of financing to further enhance its growth trajectory [2]. Technological Advancements - The company has developed several internationally leading technologies in the biobased materials production chain, including "non-grain biomass utilization," "new generation industrial strains," "gypsum-free lactic acid technology," and "rPLA recycling" [3]. - The gypsum-free lactic acid technology addresses environmental issues by eliminating gypsum waste during production, enabling cleaner and lower-cost lactic acid production [3]. - The rPLA recycling process allows for the recycling of polylactic acid (PLA), reducing production costs and creating a closed-loop lifecycle for PLA products [3]. Product Applications - PLA, the company's core product, is a high-performance biodegradable material with excellent biocompatibility, degradability, and processing capabilities, widely used in various sectors such as fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [3]. - The integrated production system enables the company to control the entire process from raw material supply to biobased material production and recycling, ensuring product quality and cost advantages [3]. Market Position and Future Outlook - The financing will primarily be used for expanding the production capacity of the scale-up base, developing new technologies, and expanding market channels [4]. - The company has achieved significant milestones in the industrialization of biobased materials, with steady growth in production capacity and market share [4]. - The founder and CEO emphasized the importance of this financing round as a milestone in the company's development, highlighting the unprecedented opportunities in the biomanufacturing sector driven by policy and market demand [4]. - The company aims to continue focusing on core technology research and expand its production scale and application scenarios to provide high-quality biobased material products and solutions [4].